Table 1.
Screening of (R) and (S)-tryptophanol-derived oxazolopyrrolidone lactams 7a–g and 8a–g in AGS cell line.
| |||
|---|---|---|---|
| Compound | R1 | R2 | % CV at 100 µM 1 |
| 7a | H | H | 50 ± 5 |
| 7b | F | H | 50 ± 8 |
| 7c | Cl | H | 6 ± 1 |
| 7d | Br | H | 14 ± 3 |
| 7e | CH3 | H | 14 ± 2 |
| 7f | OCH3 | H | 18 ± 2 |
| 7g | SO2CH3 | H | 94 ± 12 |
| 8a | H | H | 58 ± 4 |
| 8b | F | H | 22 ± 4 |
| 8c | Cl | H | 11 ± 1 |
| 8d | Br | H | 25 ± 4 |
| 8e | CH3 | H | 60 ± 3 |
| 8f | OCH3 | H | 30 ± 4 |
| 8g | SO2CH3 | H | 91 ± 11 |
1 Each % of CV (cell viability) value is the mean ± SD of triplicate of at least two different experiments. % CV determined by the MTT method after 48 h of compounds’ incubation.